SPARCL1 and metabolic dysfunction-associated steatohepatitis: Therefore, in the present work, we evaluated the prospective pharmacological role of Rosavin treatment on NASH management and its modulatory effects on hepatic cell death-related players; (HSPD1/TNF/MMP14/ITGB1) mRNAs, (miRNA-6881-5P) and (lnc-SPARCL1-1:2), that were retrieved from bioinformatics studies in NASH animal model.